Position in PRGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,117,568
+$1,798,820 QoQ
Shares Held
569,606
+83.6% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.38501350056004.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6149864994399638.ToString("F0")%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Sep 30, 2022CallValue
$2,763,650
CallShares
77,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. PRGO ranks #33 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,730,785 | $441,016,092 | |
| 2 | VTRS |
Viatris Inc
|
13,717,622 | $185,325,071 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,826,245 | $145,366,498 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
5,618,728 | $104,058,841 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,409,165 | $73,431,349 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
114,419 | $67,848,177 | |
| 7 | ALKS |
Alkermes plc.
|
1,882,178 | $66,553,812 | |
| 8 | HLN |
Haleon plc
|
6,127,452 | $61,335,793 |
All Filings in PRGO
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,117,568 | 569,606 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,318,748 | 310,255 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $12,844,154 | 576,747 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,536,334 | 918,276 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,519,893 | 1,159,768 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $13,158,017 | 511,786 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $21,445,751 | 817,604 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,369,577 | 559,563 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,955,986 | 185,026 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,303,230 | 320,175 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $5,918,193 | 185,233 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $8,558,318 | 252,086 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $9,310,631 | 259,566 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $48,199,133 | 1,413,879 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,763,650 | 77,500 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $50,677,887 | 1,421,141 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $89,232,781 | 2,199,477 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $4,158,425 | 102,500 | Call | Defined | 2024-05-14 | |
| 2022-03-31 | $118,149,536 | 3,074,409 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,556,000 | 40,000 | Call | Defined | 2022-02-17 | |
| 2021-12-31 | $100,140,540 | 2,574,307 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,893,200 | 40,000 | Call | Defined | 2022-01-20 | |
| 2021-09-30 | $42,006,037 | 887,514 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,668,000 | 80,000 | Call | Defined | 2021-08-13 | |
| 2021-06-30 | $54,804,366 | 1,195,297 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $59,665,527 | 1,474,315 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $18,140,980 | 405,657 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $42,213,785 | 919,490 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,221,911 | 637,270 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,809,000 | 100,000 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $29,856,242 | 620,841 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||